{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T04:56:15Z","timestamp":1769748975145,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002864","name":"Chonbuk National University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["2011\u20130023308"],"award-info":[{"award-number":["2011\u20130023308"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["PJ008195"],"award-info":[{"award-number":["PJ008195"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003627","name":"Rural Development Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003627","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.urolonc.2013.10.013","type":"journal-article","created":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T06:15:11Z","timestamp":1389248111000},"page":"458-465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The predictive value of GSTT1 polymorphisms in predicting the early response to induction BCG therapy in patients with non\u2013muscle invasive bladder cancer"],"prefix":"10.1016","volume":"32","author":[{"given":"Ho Won","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Un","family":"Tchey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunri","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won Tae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-June","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seok-Joong","family":"Yun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Cheol","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung Hyun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaac Yi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wun-Jae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2013.10.013_bib1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0090-4295(01)01603-X","article-title":"Long-term follow-up of G3T1 transitional cell carcinoma of the bladder treated with intravesical bacille Calmette-Gu\u00e9rin: 18-year experience","volume":"59","author":"Pansadoro","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2013.10.013_bib2","doi-asserted-by":"crossref","first-page":"631","DOI":"10.4111\/kju.2013.54.9.631","article-title":"Decreased DBC1 expression is associated with poor prognosis in patients with non-muscle-invasive bladder cancer","volume":"54","author":"Shim","year":"2013","journal-title":"Korean J Urol"},{"key":"10.1016\/j.urolonc.2013.10.013_bib3","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/cncr.24770","article-title":"Reactive antibodies against bacillus Calmette-Gu\u00e9rin heat-shock protein-65 potentially predict the outcome of immunotherapy for high-grade transitional cell carcinoma of the bladder","volume":"116","author":"Ardelt","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2013.10.013_bib4","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1158\/1078-0432.CCR-09-3323","article-title":"Gene signatures for the prediction of response to bacillus Calmette-Gu\u00e9rin immunotherapy in primary pT1 bladder cancers","volume":"16","author":"Kim","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2013.10.013_bib5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.eururo.2011.09.026","article-title":"Markers predicting response to bacillus Calmette-Gu\u00e9rin immunotherapy in high-risk bladder cancer patients: a systematic review","volume":"61","author":"Zuiverloon","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2013.10.013_bib6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1155\/2010\/816149","article-title":"GSTT1 as a prognosticator for recurrence and progression in patients with non-muscle-invasive bladder cancer","volume":"29","author":"Ha","year":"2010","journal-title":"Dis Markers"},{"key":"10.1016\/j.urolonc.2013.10.013_bib7","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1016\/j.ejca.2013.05.019","article-title":"Glutathione S-transferase M1 and T1 polymorphisms: susceptibility and outcomes in muscle invasive bladder cancer patients","volume":"49","author":"Kang","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.urolonc.2013.10.013_bib8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.eururo.2008.04.051","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder","volume":"54","author":"Babjuk","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2013.10.013_bib9","first-page":"13","article-title":"The American Joint Committee on cancer: updating the strategies in cancer staging","volume":"87","author":"Greene","year":"2002","journal-title":"Bull Am Coll Surg"},{"key":"10.1016\/j.urolonc.2013.10.013_bib10","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0140-6736(96)90468-7","article-title":"Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect","volume":"347","author":"Chen","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.urolonc.2013.10.013_bib11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1159\/000019635","article-title":"Primary bladder carcinoma in situ: assessment of early BCG response as a prognostic factor","volume":"33","author":"Orsola","year":"1998","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2013.10.013_bib12","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.eururo.2007.10.006","article-title":"Prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Gu\u00e9rin: multivariate analysis of data from four randomized CUETO trials","volume":"53","author":"Fernandez-Gomez","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2013.10.013_bib13","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","article-title":"Intravesical bacillus Calmette-Gu\u00e9rin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials","volume":"168","author":"Sylvester","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2013.10.013_bib14","first-page":"4201","article-title":"Altered p53 and pRb expression is predictive of response to BCG treatment in T1G3 bladder cancer","volume":"29","author":"Cormio","year":"2009","journal-title":"Anticancer Res"},{"key":"10.1016\/j.urolonc.2013.10.013_bib15","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0022-5347(01)61770-1","article-title":"Correlation and prognostic significance of p53, p21WAF1\/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Gu\u00e9rin intravesical therapy","volume":"161","author":"Zlotta","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2013.10.013_bib16","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/j.1464-410X.2004.05176.x","article-title":"Urine dendritic cells: a noninvasive probe for immune activity in bladder cancer?","volume":"94","author":"Beatty","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2013.10.013_bib17","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.urology.2009.02.053","article-title":"Efficacy of bacille Calmette-Gu\u00e9rin immunotherapy predicted by expression of antigen-presenting molecules and chemokines","volume":"74","author":"Videira","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2013.10.013_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2006.06.009","article-title":"Cytokine gene polymorphisms can alter the effect of bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy","volume":"35","author":"Basturk","year":"2006","journal-title":"Cytokine"},{"key":"10.1016\/j.urolonc.2013.10.013_bib19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/13547500902818246","article-title":"Cytokine gene polymorphisms are associated with risk of urinary bladder cancer and recurrence after BCG immunotherapy","volume":"14","author":"Ahirwar","year":"2009","journal-title":"Biomarkers"},{"key":"10.1016\/j.urolonc.2013.10.013_bib20","doi-asserted-by":"crossref","first-page":"645","DOI":"10.4161\/cbt.7.5.5763","article-title":"XRCC1 codon 399 mutant allele: a risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy","volume":"7","author":"Mittal","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.urolonc.2013.10.013_bib21","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00432-009-0717-y","article-title":"XPC gene variants: a risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy","volume":"136","author":"Gangwar","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.urolonc.2013.10.013_bib22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s12032-009-9187-y","article-title":"Impact of nucleotide excision repair ERCC2 and base excision repair APEX1 genes polymorphism and its association with recurrence after adjuvant BCG immunotherapy in bladder cancer patients of North India","volume":"27","author":"Gangawar","year":"2010","journal-title":"Med Oncol"},{"key":"10.1016\/j.urolonc.2013.10.013_bib23","first-page":"7130","article-title":"Polymorphisms in glutathione S-transferases (GSTM1 and GSTT1) and survival after treatment for breast cancer","volume":"61","author":"Ambrosone","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2013.10.013_bib24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/cncr.20729","article-title":"Genetic polymorphisms in glutathione-S-transferase genes (GSTM1, GSTT1, GSTP1) and survival after chemotherapy for invasive breast carcinoma","volume":"103","author":"Yang","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2013.10.013_bib25","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0140-6736(05)67137-1","article-title":"NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses","volume":"366","author":"Garcia-Closas","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.urolonc.2013.10.013_bib26","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.urolonc.2011.08.005","article-title":"GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study","volume":"31","author":"Matic","year":"2013","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2013.10.013_bib27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/carcin\/19.2.275","article-title":"Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution","volume":"19","author":"Watson","year":"1998","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.urolonc.2013.10.013_bib28","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0140-6736(00)02631-3","article-title":"Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China","volume":"356","author":"London","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.urolonc.2013.10.013_bib29","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S0006-2952(98)00191-9","article-title":"Concordance between enzyme activity and genotype of glutathione S-transferase theta (GSTT1)","volume":"56","author":"Bruhn","year":"1998","journal-title":"Biochem Pharmacol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143913004559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143913004559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:01:43Z","timestamp":1761040903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143913004559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S1078143913004559"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2013.10.013","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The predictive value of GSTT1 polymorphisms in predicting the early response to induction BCG therapy in patients with non\u2013muscle invasive bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2013.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}